This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Menzies, V. Articles by Farrell, S. P. Search for Related Content Social Bookmarking                         What's this?

Schizophrenia, Tardive Dyskinesia, and the Abnormal Involuntary Movement Scale (AIMS)

School of Nursing, University of Virginia

Sarah P. Farrell, RN, CS, PhD

School of Nursing, University of Virginia

The incidence of tardive dyskinesia as a side effect of antipsychotic medications is well documented in the literature on the treatment for schizophrenia. Although the new generation of atypical neuroleptics helps diminish the incidence of such side effects, a complete elimination has yet to be fully realized. Nurses continually observe and assess patients. As such, nurses in all settings can effectively contribute to both preventative and palliative care of the patient who is about to receive or is currently receiving antipsychotic medications. Familiarity with the Abnormal Involuntary Movement Scale (AIMS) and expertise in the application of AIMS in patient assessment assist in these important prevention efforts.

Journal of the American Psychiatric Nurses Association, Vol. 8, No. 2, 51-56 (2002)
DOI: 10.1067/mpn.2002.124918


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?